Overview
Graham Abra is a Nephrologist in Stanford, California. Dr. Abra is rated as an Experienced provider by MediFind in the treatment of Megalencephalic Leukoencephalopathy with Subcortical Cysts. His top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), IgA Nephropathy, and Glomerulonephritis.
His clinical research consists of co-authoring 33 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
Accepted plan types not found. Please verify directly with the provider.
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- INSURANCE PLAN
- MEDICARE MAPD
- EPO
- HMO
- POS
- PPO
- HMO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
300 Pasteur Dr, Stanford, CA 94305
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Lpch Medical Group Div Of Lucile
Ruby Patel is a Pediatric Nephrologist and a Pediatrics provider in Palo Alto, California. Dr. Patel is rated as an Advanced provider by MediFind in the treatment of Megalencephalic Leukoencephalopathy with Subcortical Cysts. Her top areas of expertise are Autosomal Recessive Polycystic Kidney Disease, Potter Syndrome, Feingold Syndrome, and Congenital Nephrotic Syndrome.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic Kidney DiseaseDr. Abra isDistinguished. Learn about Chronic Kidney Disease.
- End-Stage Renal Disease (ESRD)Dr. Abra isDistinguished. Learn about End-Stage Renal Disease (ESRD).
- Advanced
- Acute Kidney FailureDr. Abra isAdvanced. Learn about Acute Kidney Failure.
- Autosomal Dominant Polycystic Kidney Disease
- GlomerulonephritisDr. Abra isAdvanced. Learn about Glomerulonephritis.
- IgA NephropathyDr. Abra isAdvanced. Learn about IgA Nephropathy.
- Lupus NephritisDr. Abra isAdvanced. Learn about Lupus Nephritis.
- Polycystic Kidney DiseaseDr. Abra isAdvanced. Learn about Polycystic Kidney Disease.
- Experienced
- Alport SyndromeDr. Abra isExperienced. Learn about Alport Syndrome.
- BoilsDr. Abra isExperienced. Learn about Boils.
- CarbuncleDr. Abra isExperienced. Learn about Carbuncle.
- Childhood Hypophosphatasia (HPP)Dr. Abra isExperienced. Learn about Childhood Hypophosphatasia (HPP).
- Congenital Nephrotic SyndromeDr. Abra isExperienced. Learn about Congenital Nephrotic Syndrome.
- Diabetic NephropathyDr. Abra isExperienced. Learn about Diabetic Nephropathy.